Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 526 (ZNF526) is a member of the zinc finger protein family characterized by the presence of C2H2-type zinc finger domains, which typically function as DNA-binding motifs involved in transcriptional regulation[2][3][1]. ZNF526 is predicted to enable sequence-specific DNA binding and participate in the regulation of gene expression by RNA polymerase II[3]. It is primarily localized to the cell nucleus[3]. Biallelic variants in ZNF526 have been associated with a severe neurodevelopmental disorder that includes microcephaly, epilepsy, bilateral cataracts, and simplified brain gyration[6][1]. There is no evidence that ZNF526 is currently considered a therapeutic target, nor are there known drugs that directly interact with this protein. Its main recognized relevance is in the context of rare congenital neurodevelopmental diseases[6][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 526 (ZNF526).